Profile data is unavailable for this security.
About the company
Haw Par Corporation Limited is a Singapore-based holding company. The principal activities of the Company are licensing the Tiger trademarks and owning and holding investments for the long-term. Its segments include Healthcare products, Investments and Others. Its Healthcare products segment is engaged in manufacturing and distributing topical analgesic products under the Tiger Balm and Kwan Loong brands. Its Investments segment is engaged in long term investing activities, mainly in quoted securities in Asia. Its Others segment includes the property division, which owns and leases out several investment properties in Asia, and the leisure division, which provides family and tourist-oriented leisure activities in the form of oceanariums. Its Tiger Balm brand offers products such as Tiger Balm White Ointment, Tiger Balm Muscle Rub, Tiger Balm Back Pain Patch, and Tiger Balm Muscle Rub. Its Kwan Loong brand offers products such as Kwan Loong Medicated Oil and Kwan Loong Refresher.
- Revenue in SGD (TTM)239.06m
- Net income in SGD234.43m
- Incorporated1969
- Employees595.00
- LocationHaw Par Corporation Ltd401 Commonwealth Drive#03-03 Haw Par Techno Centre 149598SingaporeSGP
- Phone+65 63379102
- Fax+65 63369232
- Websitehttps://www.hawpar.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caplin Point Laboratories Ltd | 291.74m | 78.65m | 2.35bn | 859.00 | 30.02 | 5.81 | 26.38 | 8.07 | 64.73 | 64.73 | 240.10 | 334.54 | 0.6861 | 2.28 | 3.40 | 21,312,920.00 | 18.62 | 19.83 | 21.36 | 22.82 | 58.72 | 53.38 | 27.14 | 25.39 | 5.07 | 932.86 | 0.0009 | 9.06 | 15.50 | 21.17 | 21.48 | 20.95 | 17.47 | 17.84 |
| 3SBio Inc | 1.57bn | 308.26m | 2.36bn | 5.61k | 7.78 | 0.8822 | 6.17 | 1.51 | 0.7314 | 0.7314 | 3.71 | 6.45 | 0.3575 | 1.52 | 6.87 | 1,671,849.00 | 7.25 | 7.44 | 10.26 | 9.29 | 85.94 | 82.91 | 20.27 | 21.50 | 1.57 | 141.55 | 0.1998 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
| Tarsus Pharmaceuticals Inc | 174.54m | -180.90m | 2.38bn | 244.00 | -- | 7.46 | -- | 13.62 | -3.76 | -3.76 | 3.58 | 6.22 | 0.4022 | 6.37 | 7.51 | 531,233.60 | -41.68 | -31.56 | -48.37 | -33.82 | 92.97 | -- | -103.64 | -242.59 | 5.38 | -- | 0.2319 | -- | -32.42 | -- | -118.86 | -- | 279.39 | -- |
| Jiangxi Tianxin Pharmaceutical Co Ltd | 373.64m | 103.71m | 2.43bn | 2.47k | 23.42 | 2.93 | -- | 6.49 | 1.27 | 1.27 | 4.58 | 10.18 | 0.3977 | 2.75 | 10.26 | 812,720.60 | 11.04 | -- | 11.82 | -- | 41.64 | -- | 27.76 | -- | 6.39 | -- | 0.0234 | -- | -18.34 | -- | -23.51 | -- | -- | -- |
| Haw Par Corporation Ltd | 239.06m | 234.43m | 2.47bn | 595.00 | 10.55 | 0.6696 | 10.29 | 10.35 | 1.06 | 1.06 | 1.08 | 16.70 | 0.0653 | 5.06 | 4.98 | -- | 6.41 | 4.73 | 6.61 | 4.85 | 57.06 | 54.42 | 98.06 | 85.35 | 4.49 | -- | 0.0097 | 45.57 | 27.44 | -0.4885 | 46.02 | 3.88 | 18.24 | 5.92 |
| Jiang Zhong Pharmaceutical Co Ltd | 785.50m | 140.13m | 2.49bn | 4.01k | 17.73 | 3.60 | -- | 3.17 | 1.20 | 1.20 | 6.71 | 5.91 | 0.6828 | 3.58 | 15.12 | 1,052,061.00 | 13.36 | 10.82 | 20.72 | 15.08 | 63.72 | 65.02 | 19.56 | 18.17 | 0.8833 | -- | 0.0004 | 82.88 | 13.00 | 20.12 | 18.40 | 8.54 | 11.47 | 40.99 |
| Almirall SA | 1.34bn | -63.33m | 2.50bn | 2.00k | -- | 1.21 | -- | 1.87 | -0.2127 | -0.2127 | 4.56 | 6.87 | 0.4069 | 1.34 | 6.53 | 497,675.40 | -1.93 | 0.922 | -2.17 | 1.08 | 76.69 | 78.06 | -4.74 | 2.48 | 1.99 | 394.32 | 0.1912 | -- | 3.62 | 3.40 | -998.72 | -- | -23.27 | -- |
| BrightGene Bio-Medical Technology Co Ltd | 230.98m | 34.99m | 2.51bn | 1.16k | 71.43 | 5.72 | -- | 10.86 | 0.4466 | 0.4466 | 2.96 | 5.57 | 0.2522 | 1.63 | 3.50 | 1,074,862.00 | 2.91 | 6.53 | 3.57 | 7.93 | 54.97 | 56.93 | 11.55 | 19.90 | 1.18 | 4.53 | 0.4841 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
| Astrazeneca Pharma India Ltd | 236.56m | 13.05m | 2.51bn | 940.00 | 192.45 | 23.20 | 153.62 | 10.62 | 32.76 | 32.76 | 593.93 | 271.74 | 1.27 | 2.52 | 10.63 | 15,792,680.00 | 6.99 | 11.78 | 11.44 | 19.62 | 44.88 | 54.64 | 5.52 | 10.27 | 1.44 | 134.82 | 0.0246 | 25.62 | 29.17 | 12.21 | 62.66 | 24.29 | -10.46 | -- |
| Endo Inc | -134.65bn | -134.65bn | 2.52bn | 3.00k | -- | 1.02 | -- | -- | -- | -- | -- | 23.99 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.52 | -- | 0.5697 | -- | -13.25 | -- | 15.87 | -- | -- | -- |
| Nippon Shinyaku Co., Ltd. | 1.34bn | 226.97m | 2.54bn | 2.21k | 10.74 | 1.19 | 9.24 | 1.89 | 386.74 | 386.74 | 2,290.53 | 3,486.81 | 0.5956 | 1.29 | 3.36 | 69,711,700.00 | 10.06 | 10.45 | 11.39 | 12.31 | 67.69 | 61.27 | 16.89 | 16.47 | 4.22 | -- | 0.0107 | 32.62 | 2.83 | 5.26 | 13.32 | 9.66 | 45.93 | 12.12 |
| Harmony Biosciences Holdings Inc | 918.18m | 165.12m | 2.55bn | 246.00 | 15.73 | 3.18 | 12.90 | 2.78 | 2.11 | 2.11 | 11.75 | 10.46 | 0.7994 | 24.26 | 9.17 | 2,771,866.00 | 14.38 | 7.46 | 17.12 | 9.08 | 78.65 | 80.58 | 17.98 | 10.46 | 3.20 | -- | 0.2345 | 0.00 | 32.93 | -- | -28.99 | -- | -25.31 | -- |
Data as of Nov 22 2024. Currency figures normalised to Haw Par Corporation Ltd's reporting currency: Singapore Dollar SGD
17.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| First Eagle Investment Management LLCas of 04 Mar 2024 | 22.30m | 10.08% |
| Kayne Anderson Rudnick Investment Management LLCas of 04 Mar 2024 | 12.08m | 5.46% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 1.79m | 0.81% |
| State Board of Administration of Florida Retirement Systemas of 30 Jun 2024 | 685.50k | 0.31% |
| Healthinvest Partners ABas of 31 Dec 2023 | 620.00k | 0.28% |
| First Sentier Investors (Singapore)as of 31 Jul 2024 | 601.00k | 0.27% |
| WCM Investment Management LLCas of 30 Sep 2024 | 592.90k | 0.27% |
| First Sentier Investors (Hong Kong) Ltd.as of 31 Jul 2024 | 335.80k | 0.15% |
| Phillip Capital Management (S) Ltd.as of 30 Jun 2024 | 166.00k | 0.08% |
| Dimensional Fund Advisors Ltd.as of 31 Aug 2024 | 151.10k | 0.07% |
More ▼
Data from 30 Sep 2024 - 07 Nov 2024Source: FactSet Research Systems Inc.
